Restoration of Ovarian Endocrine Function

TECHNOLOGY NUMBER: 6651
Technology No. 6651

OVERVIEW

Bioengineered matrix for restoring ovarian endocrine function.
  • Provides immune-isolated delivery of natural estrogen and progesterone with normal physiological regulation, avoiding HRT side effects and cancer cell reintroduction risks.
  • Restoring ovarian function in cancer survivors with premature ovarian failure and treating menopausal symptoms.


BACKGROUND

Premature ovarian failure (POF) frequently results from anticancer treatments, including toxic chemotherapy, radiotherapy, and bone marrow transplantation. Existing treatment options are limited to hormone replacement therapy (HRT) and autologous ovarian tissue transplantation. However, HRT delivers unregulated, non-physiological levels of estrogen and causes adverse side effects. Autotransplantation carries the risk of reintroducing cancer cells into the patient and requires tissue cryopreservation prior to cancer treatment. Consequently, there is a strong need for safe therapies that restore natural, physiologically regulated sex hormone production.


INNOVATION

This technology uses a bioengineered matrix to support ovarian follicle survival and function within an immune-privileged environment, preventing rejection while producing estrogen and progesterone under physiological regulation. The design features a combined hydrogel device with a non-degradable polymeric outer shell and a degradable polymeric inner core implanted with ovarian tissue. The outer shell provides immunoisolation while allowing the exchange of nutrients, oxygen, and hormones. The degradable inner core expands as the encapsulated ovarian tissue grows. This approach eliminates the risks of cancer reintroduction and non-physiological dosing, offering a significant quality-of-life improvement for patients.


ADDITIONAL INFORMATION

REFERENCES

Kunpeng Huang, Yasha Iravantchi, Dongyao Chen, Alanson P. Sample,, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, Volume 8, Issue 4, Article No.: 170, Pages 1 - 31. https://doi.org/10.1145/3699756


INTELLECTUAL PROPERTY

US10918673B2 "Immunoisolation device"


RELATED TECHNOLOGY


  • expand_more mode_edit Inventor (1)
    Ariella Shikanov
  • expand_more cloud_download Supporting documents (1)
    Product brochure
    Restoration of Ovarian Endocrine Function.pdf
Questions about this technology?